- Home
- MRNA vs FMS Comparison
MRNA vs FMS Comparison
Compare MRNA & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- FMS
- Stock Information
- Founded
- MRNA 2010
- FMS 1996
- Country
- MRNA United States
- FMS Germany
- Employees
- MRNA N/A
- FMS N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- FMS Misc Health and Biotechnology Services
- Sector
- MRNA Health Care
- FMS Health Care
- Exchange
- MRNA Nasdaq
- FMS Nasdaq
- Market Cap
- MRNA 16.5B
- FMS 14.1B
- IPO Year
- MRNA 2018
- FMS 1996
- Fundamental
- Price
- MRNA $38.36
- FMS $23.02
- Analyst Decision
- MRNA Hold
- FMS Hold
- Analyst Count
- MRNA 19
- FMS 1
- Target Price
- MRNA $79.50
- FMS $23.00
- AVG Volume (30 Days)
- MRNA 7.7M
- FMS 215.5K
- Earning Date
- MRNA 11-07-2024
- FMS 02-18-2025
- Dividend Yield
- MRNA N/A
- FMS 2.73%
- EPS Growth
- MRNA N/A
- FMS 46.47
- EPS
- MRNA N/A
- FMS 2.50
- Revenue
- MRNA $5,081,000,000.00
- FMS $21,457,738,113.00
- Revenue This Year
- MRNA N/A
- FMS $0.24
- Revenue Next Year
- MRNA N/A
- FMS $3.41
- P/E Ratio
- MRNA N/A
- FMS $18.85
- Revenue Growth
- MRNA N/A
- FMS N/A
- 52 Week Low
- MRNA $35.80
- FMS $17.93
- 52 Week High
- MRNA $170.47
- FMS $24.31
- Technical
- Relative Strength Index (RSI)
- MRNA 35.63
- FMS 52.85
- Support Level
- MRNA $41.06
- FMS $23.58
- Resistance Level
- MRNA $44.38
- FMS $24.07
- Average True Range (ATR)
- MRNA 2.57
- FMS 0.31
- MACD
- MRNA 0.16
- FMS -0.09
- Stochastic Oscillator
- MRNA 1.74
- FMS 47.98
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.